These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29099951)

  • 1. TumorFusions: an integrative resource for cancer-associated transcript fusions.
    Hu X; Wang Q; Tang M; Barthel F; Amin S; Yoshihara K; Lang FM; Martinez-Ledesma E; Lee SH; Zheng S; Verhaak RGW
    Nucleic Acids Res; 2018 Jan; 46(D1):D1144-D1149. PubMed ID: 29099951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FusionGDB: fusion gene annotation DataBase.
    Kim P; Zhou X
    Nucleic Acids Res; 2019 Jan; 47(D1):D994-D1004. PubMed ID: 30407583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
    Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
    BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. canEvolve: a web portal for integrative oncogenomics.
    Samur MK; Yan Z; Wang X; Cao Q; Munshi NC; Li C; Shah PK
    PLoS One; 2013; 8(2):e56228. PubMed ID: 23418540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
    Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
    Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic hotspots but few recurrent fusion genes in breast cancer.
    Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
    Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions.
    Shugay M; Ortiz de Mendíbil I; Vizmanos JL; Novo FJ
    Bioinformatics; 2013 Oct; 29(20):2539-46. PubMed ID: 23956304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
    Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
    Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic basis for RNA alterations in cancer.
    ; Calabrese C; Davidson NR; Demircioğlu D; Fonseca NA; He Y; Kahles A; Lehmann KV; Liu F; Shiraishi Y; Soulette CM; Urban L; Greger L; Li S; Liu D; Perry MD; Xiang Q; Zhang F; Zhang J; Bailey P; Erkek S; Hoadley KA; Hou Y; Huska MR; Kilpinen H; Korbel JO; Marin MG; Markowski J; Nandi T; Pan-Hammarström Q; Pedamallu CS; Siebert R; Stark SG; Su H; Tan P; Waszak SM; Yung C; Zhu S; Awadalla P; Creighton CJ; Meyerson M; Ouellette BFF; Wu K; Yang H; ; Brazma A; Brooks AN; Göke J; Rätsch G; Schwarz RF; Stegle O; Zhang Z;
    Nature; 2020 Feb; 578(7793):129-136. PubMed ID: 32025019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting and visualizing gene fusions.
    Supper J; Gugenmus C; Wollnik J; Drueke T; Scherf M; Hahn A; Grote K; Bretschneider N; Klocke B; Zinser C; Cartharius K; Seifert M
    Methods; 2013 Jan; 59(1):S24-8. PubMed ID: 23036331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.
    Paciello G; Ficarra E
    BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.
    Yang J; Li Q; Noureen N; Fang Y; Kurmasheva R; Houghton PJ; Wang X; Zheng S
    Nucleic Acids Res; 2021 Jan; 49(D1):D1321-D1327. PubMed ID: 32810235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
    Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
    J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.